A randomized trial of hyperimmune globulin to prevent congenital cytomegalovirus.
about
Human cytomegalovirus vaccine based on the envelope gH/gL pentamer complexDengue Virus Envelope Dimer Epitope Monoclonal Antibodies Isolated from Dengue Patients Are Protective against Zika VirusCytomegalovirus Infection May Contribute to the Reduced Immune Function, Growth, Development, and Health of HIV-Exposed, Uninfected African ChildrenVirion Glycoprotein-Mediated Immune Evasion by Human Cytomegalovirus: a Sticky Virus Makes a Slick GetawayInfections and Brain DevelopmentEmerging Role of Zika Virus in Adverse Fetal and Neonatal OutcomesCongenital cytomegalovirus infection: Clinical presentation, epidemiology, diagnosis and preventionImmunobiology of congenital cytomegalovirus infection of the central nervous system—the murine cytomegalovirus modelMechanism for neutralizing activity by the anti-CMV gH/gL monoclonal antibody MSL-109The immunological underpinnings of vaccinations to prevent cytomegalovirus disease.Cytomegalovirus infection in pregnancyUse of human immunoglobulins as an anti-infective treatment: the experience so far and their possible re-emerging role.Educating women about congenital cytomegalovirus: assessment of health education materials through a web-based survey.Prevention of Primary Cytomegalovirus Infection in Pregnancy.Congenital Cytomegalovirus infection: advances and challenges in diagnosis, prevention and treatmentPreexisting antibodies can protect against congenital cytomegalovirus infection in monkeys.Mother-to-Child Transmission of Cytomegalovirus and Prevention of Congenital InfectionImmunity to cytomegalovirus in early life.Perinatal cytomegalovirus and varicella zoster virus infections: epidemiology, prevention, and treatment.Antibody-driven design of a human cytomegalovirus gHgLpUL128L subunit vaccine that selectively elicits potent neutralizing antibodiesA high-affinity native human antibody neutralizes human cytomegalovirus infection of diverse cell typesHuman cytomegalovirus infection interferes with the maintenance and differentiation of trophoblast progenitor cells of the human placentaPhase 1 Randomized, Double-Blind, Placebo-Controlled Study of RG7667, an Anticytomegalovirus Combination Monoclonal Antibody Therapy, in Healthy Adults.Prediction of Maternal Cytomegalovirus Serostatus in Early Pregnancy: A Retrospective Analysis in Western Europe.The March towards a Vaccine for Congenital CMV: Rationale and Models.Maternal CD4+ T cells protect against severe congenital cytomegalovirus disease in a novel nonhuman primate model of placental cytomegalovirus transmission.Vaccine-Derived Neutralizing Antibodies to the Human Cytomegalovirus gH/gL Pentamer Potently Block Primary Cytotrophoblast Infection.Awareness of Cytomegalovirus Infection among Pregnant Women in Geneva, Switzerland: A Cross-sectional Study.Risk of congenital cytomegalovirus infection among HIV-exposed uninfected infants is not decreased by maternal nelfinavir use during pregnancy.Preventing Congenital Cytomegalovirus Infection: Protection to a 'T'.Comparison of the Cytomegalovirus (CMV) Enzyme-Linked Immunosorbent Spot and CMV QuantiFERON Cell-Mediated Immune Assays in CMV-Seropositive and -Seronegative Pregnant and Nonpregnant Women.Advances in the prevention and treatment of congenital cytomegalovirus infectionIn Vitro Characterization of Human Cytomegalovirus-Targeting Therapeutic Monoclonal Antibodies LJP538 and LJP539.Evaluation of T Cell Immunity against Human Cytomegalovirus: Impact on Patient Management and Risk Assessment of Vertical TransmissionFunctional screening for anti-CMV biologics identifies a broadly neutralizing epitope of an essential envelope proteinPassive Immunoprophylaxis for the Protection of the Mother and Her Baby: Insights from In Vivo Models of Antibody TransportCytomegalovirus in pregnancy and the neonate.Primary Human Cytomegalovirus (HCMV) Infection in Pregnancy.Neutralization of Diverse Human Cytomegalovirus Strains Conferred by Antibodies Targeting Viral gH/gL/pUL128-131 Pentameric Complex.Design and development of antivirals and intervention strategies against human herpesviruses using high-throughput approach.
P2860
Q21089588-C7DC11BD-0853-4ACC-9F7E-86B2CD7E5693Q26247258-AE4A8FBE-2269-440C-9B0B-6BB91734212BQ26742161-9143EB0C-0D21-40A9-893E-E5D97D685871Q26745798-C04890C9-9415-4E59-89D5-DEBA2CEB3905Q26778598-59E793DF-CB3E-400D-A0AB-209E9040BCDCQ27010776-D499287A-9254-4657-AC32-75AA53E276DAQ27024030-356A2D00-0D48-45E5-AA7D-23BA6D21CD1FQ27026924-2E7AFF38-DC72-47C5-AB79-E3AEDB9F259AQ27683850-D01C07D4-82ED-40CF-9C68-DFD78EE3AAC4Q27692570-C37F6F18-77D2-4965-931C-FEB0806692A0Q29994481-6F07C6E1-998E-4F11-9130-7A042CB23499Q30145641-047263B7-8147-4E18-BC8C-236ADCD7BB53Q30606105-2BFF6858-C9F8-4D55-AAAC-D4C9E63E8432Q30666266-5BCB006B-E7F7-4876-970C-B1D3B1DE5B46Q33568646-877FCB8E-3090-4517-AE4C-A20267BF2627Q33877783-970DBBA8-3FC0-4894-AB12-233C85BC55B7Q34181689-A56E2781-AD6C-4D5A-889B-EDA90FA78A84Q34426299-78844025-9FCD-469F-B3C2-4D26837BFC3CQ34667953-BD59877E-39A9-4B55-8C80-490F1316FF31Q34753135-BD5FEB2D-254C-4DEA-A065-ED254387C67CQ35076970-52837BAB-C2E7-407D-BDCA-6F5035239334Q35488673-F6780198-B892-4B1B-971E-D0C523903536Q35859879-B358AC6E-9F6F-4C21-81DE-81141A7F7410Q35875262-8427E5EC-5967-4E95-A724-3660EF1CBFFBQ35920807-D489823C-25BD-4A19-9E83-B6A82B214B06Q36268583-B3EDE069-3F0E-42AF-8642-29D3CC506DAAQ36281094-62511279-0004-4278-9B6D-0C1CF17842CDQ36403590-0C4BF9DB-EEED-4D85-B5FB-996EC9F86BFFQ36757599-E7E4A610-AD6E-494A-B7C7-6C9285A295A0Q36812617-AA2CCF8D-D5D0-4781-ABB8-550070184AD6Q36834814-CCE1E7D3-D696-401E-AC81-6656CF44580DQ37006043-3DE4ED25-EA36-43DB-A6E9-2B4E2EE0BD0FQ37120061-E0DFD058-1487-4601-870B-AC3F94448EC0Q37504023-06F70DC8-38DD-46C4-A8F8-B1A9E8B6E98AQ37519151-123188E6-F825-44D5-A302-4D31476795E6Q37607552-2888AA36-EB3A-49F8-9555-9A70395EA1ABQ37643347-31E01F40-D3EA-4461-8D08-1109D39FB11EQ37656015-4D34293D-6122-4E42-82C8-5CE0DFF05DB2Q37707461-A4894EFF-4487-4999-85C2-EB3589B8358DQ38227257-20AC33AB-188B-4FD2-9968-8D3312502845
P2860
A randomized trial of hyperimmune globulin to prevent congenital cytomegalovirus.
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
A randomized trial of hyperimmune globulin to prevent congenital cytomegalovirus.
@ast
A randomized trial of hyperimmune globulin to prevent congenital cytomegalovirus.
@en
A randomized trial of hyperimmune globulin to prevent congenital cytomegalovirus.
@nl
type
label
A randomized trial of hyperimmune globulin to prevent congenital cytomegalovirus.
@ast
A randomized trial of hyperimmune globulin to prevent congenital cytomegalovirus.
@en
A randomized trial of hyperimmune globulin to prevent congenital cytomegalovirus.
@nl
prefLabel
A randomized trial of hyperimmune globulin to prevent congenital cytomegalovirus.
@ast
A randomized trial of hyperimmune globulin to prevent congenital cytomegalovirus.
@en
A randomized trial of hyperimmune globulin to prevent congenital cytomegalovirus.
@nl
P2093
P50
P356
P1476
A randomized trial of hyperimmune globulin to prevent congenital cytomegalovirus
@en
P2093
Alessia Arossa
Arsenio Spinillo
Brunella Guerra
CHIP Study Group
Enrico Ferrazzi
Giuseppe Gerna
Liliana Gabrielli
Maria Grazia Revello
Milena Furione
Nicola Rizzo
P304
P356
10.1056/NEJMOA1310214
P407
P577
2014-04-01T00:00:00Z